Jpmorgan Chase & CO Elanco Animal Health Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,057,656 shares of ELAN stock, worth $121 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,057,656
Previous 5,695,857 76.58%
Holding current value
$121 Million
Previous $82.2 Million 79.64%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$11.85 - $15.47 $51.7 Million - $67.5 Million
4,361,799 Added 76.58%
10,057,656 $148 Million
Q3 2024

Nov 08, 2024
BUY
$11.85 - $15.47 $51.7 Million - $67.5 Million
4,361,799 Added 76.58%
10,057,656 $148 Million
Q2 2024

Dec 26, 2024
SELL
$12.93 - $18.45 $56.4 Million - $80.5 Million
-4,361,799 Reduced 43.37%
5,695,857 $82.2 Million
Q2 2024

Aug 12, 2024
SELL
$12.93 - $18.45 $16.9 Million - $24.2 Million
-1,309,246 Reduced 18.69%
5,695,857 $82.2 Million
Q1 2024

Dec 26, 2024
SELL
$14.37 - $16.46 $43.9 Million - $50.2 Million
-3,052,553 Reduced 30.35%
7,005,103 $114 Million
Q1 2024

May 10, 2024
BUY
$14.37 - $16.46 $8.97 Million - $10.3 Million
624,197 Added 9.78%
7,005,103 $114 Million
Q4 2023

Dec 26, 2024
SELL
$8.6 - $14.94 $31.6 Million - $54.9 Million
-3,676,750 Reduced 36.56%
6,380,906 $95.1 Million
Q4 2023

Feb 12, 2024
BUY
$8.6 - $14.94 $9.68 Million - $16.8 Million
1,125,888 Added 21.43%
6,380,906 $95.1 Million
Q3 2023

Nov 14, 2023
BUY
$9.81 - $12.62 $3.18 Million - $4.09 Million
324,308 Added 6.58%
5,255,018 $59.1 Million
Q2 2023

Aug 11, 2023
SELL
$8.08 - $10.37 $49.6 Million - $63.7 Million
-6,143,203 Reduced 55.47%
4,930,710 $49.6 Million
Q1 2023

May 18, 2023
BUY
$8.79 - $14.58 $161,779 - $268,344
18,405 Added 0.17%
11,073,913 $104 Million
Q1 2023

May 11, 2023
BUY
$8.79 - $14.58 $65.9 Million - $109 Million
7,497,967 Added 210.76%
11,055,508 $104 Million
Q4 2022

Feb 13, 2023
BUY
$11.49 - $13.65 $16 Million - $19.1 Million
1,396,140 Added 64.59%
3,557,541 $43.5 Million
Q3 2022

Nov 14, 2022
BUY
$12.41 - $32.42 $20.5 Million - $53.7 Million
1,654,968 Added 326.79%
2,161,401 $26.8 Million
Q2 2022

Aug 11, 2022
BUY
$19.63 - $26.62 $2.97 Million - $4.03 Million
151,429 Added 42.66%
506,433 $9.94 Million
Q1 2022

May 11, 2022
BUY
$24.65 - $29.0 $1.18 Million - $1.39 Million
47,881 Added 15.59%
355,004 $9.26 Million
Q4 2021

Feb 10, 2022
BUY
$27.74 - $34.09 $3.76 Million - $4.62 Million
135,470 Added 78.92%
307,123 $8.72 Million
Q3 2021

Nov 12, 2021
BUY
$29.2 - $36.72 $5.01 Million - $6.3 Million
171,653 New
171,653 $5.47 Million

Others Institutions Holding ELAN

# of Institutions
435
Shares Held
472M
Call Options Held
4.62M
Put Options Held
753K
View Full List

About Elanco Animal Health Inc

ELAN Quotes by TradingView
  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.69B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email